Stryker, Zimmer Biomet, Medtronic & more: 11 device company notes

Written by Mackenzie Garrity | May 02, 2018 | Print  |

Here are 11 key notes orthopedic and spine device companies from the past week.

Zimmer Biomet showcased a new technology platform for its craniomaxillofacial, bone healing and spine business units at the American Association of Neurological Surgeons Annual Meeting, April 28 to May 2, in New Orleans.

Zimmer Biomet partnered with nonprofit Faith In Practice to expand the access of implants to underserved communities.

Although NuVasive reported first quarter 2018 revenues increased 4.6 percent year-over-year to $260.5 million, the company still reported a net loss.

Safe Orthopaedics reported its first quarter 2018 revenues and full-year 2017 results.

K2M hosted its annual Meeting of Minds, in Chicago, April 20 to April 21. The symposium is K2M's largest comprehensive medical education program.

Orthofix reported a 5.8 percent increase in net sales for the first quarter of 2018.

In the first quarter of 2018, Stryker saw growth in all aspects of its business. The company released its financial results to provide further detail.

A Los Angeles County jury found William Dobkin, MD, of Newport Beach, Calif.-based Hoag Hospital, not negligent in a case involving the off-label use of Medtronic's Infuse.

CoreLink named David Castleman its inaugural vice president of research and development.

Implanet reported first quarter revenue dropped 9 percent over the same time last year.

Zimmer Biomet partnered with Warsaw (Ind.) Community Schools to continuing expanding STEM initiatives.

More articles on devices and implants:
Zimmer Biomet presents new technology platform for spine business: 4 observations
Zimmer Biomet makes new partnership to expand implant access: 3 notes
NuVasive reports 4.6% Q1 revenue growth, $27.1M net loss: 5 key points

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months